Performance of the Study 1 Sample Clauses

Performance of the Study 1. Provádění studie 1.1 Institution xxxxx serve as the prehises and facifities focated at where the Study wiff be undertaken by Investingator accordinng to the terhs and conditions set forth in this Angreehent. Institution nguarantees that the appropriate facifities (incfudinng any equiphent, but excfudinng those to be provided by Sponsor or WCT for the Study) necessary and adequate for conductinng the Study are avaifabfe at Institution. Institution and Investingator have read and understood the Protocof and aff the inforhation in the investingator's brochure provided by Sponsor, incfudinng the potentiaf risks and side efects of the Study drungs. Institution represents that Investingator has appropriate experience in the diangnosis and treathent of patients with severe or profound sudden sensorineuraf hearinng foss, 1.1 Poskytovatefposkytne prostory a zařízení v hístě, kde bude zkoušející studii v soufadu s podhínkahi této shfouvy provádět. Poskytovatef zaručuje, že u poskytovatefe budou k dispozici vhodné prostředky a zařízení (včetně vybavení, vyjha toho, které poskytne zadavatef nebo spofečnost WCT) potřebné k provádění studie. Poskytovatef a zkoušející si přečetfi protokof a veškeré inforhace v souboru inforhací pro zkoušejícího předané zadavatefeh, včetně potenciáfních rizik a vedfejších účinků hodnocených přípravků, a porozuhěfi jih. Poskytovatef prohfašuje, že zkoušející há patřičné zkušenosti s diangnostikou a féčbou pacientů sezávažnou nebo těžkou náhfou senzorineuráfní ztrátou
Sample 1See All (5)
AutoNDA by SimpleDocs
Performance of the Study 1. Provádění studie 1.1 Institution shall serve as the premises and facilities located at where the Study will be undertaken by Investigator according to the terms and conditions set forth in this Agreement. Institution guarantees that the appropriate facilities (including any equipment, but excluding those to be provided by Sponsor or WORLDWIDE for the Study) necessary and adequate for conducting the Study are available at Institution. Investigator acknowledges that he/she has read and understands the Protocol and all the information in the investigator's 1.1 Zdravotnické zařízení bude působit jako prostor a zařízení v místě provádění studie zkoušejícím lékařem, a to za podmínek stanovených v této smlouvě. Zdravotnické zařízení zaručuje, že je ve zdravotnickém zařízení k dispozici veškeré zařízení nezbytné a vhodné k provádění studie (včetně veškerého vybavení, avšak s výjimkou vybavení, které má poskytnout zadavatel nebo společnost WORLDWIDE). Zkoušející lékař potvrzuje, že si přečetl protokol a veškeré informace v souboru informací pro zkoušejícího lékaře, které poskytl
Sample 1
Performance of the Study 1. Provádění studie 1.1. Institution and Principal Investigator shall, and shall cause Study Staff to conduct the Study in accordance with this Agreement, the Protocol, all Study Instructions, Applicable Laws, namely Act No. 378/2007 Coll., on Pharmaceuticals, as amended and Decree No. 226/2008 Coll. on good clinical practice and detailed conditions of clinical trials on medicinal products, as amended, and any professional standards applicable to their professional industries as in force at the time of performance of the Study (e.g., International Conference on 1. 1. Zdravotnické zařízení a Hlavní zkoušející a přimějí veškerý Personál studie, aby prováděl Studii v souladu s touto Smlouvou, Protokolem, veškerými Pokyny ke studii, Platnými právními předpisy, jmenovitě zákonem č. 378/2007 Sb. o léčivech ve znění pozdějších předpisů a vyhlášky č. 226/2008 Sb. o správné klinické praxi a bližších podmínkách klinického hodnocení léčivých přípravků ve znění pozdějších předpisů, a veškerými profesními normami platnými pro příslušné profesní odvětví ve znění platném v čase provádění Studie (např. Mezinárodní konference pro Harmonization-Good Clinical Practice) or as they may be amended or replaced at any time. harmonizaci o správné klinické praxi) nebo kdykoli, kdy mohou být změněny nebo nahrazeny. 1.2. The Protocol is made part of this Agreement and is incorporated by reference herein. Neither Institution nor Principal Investigator will, nor permit any Study Staff to, deviate from the Protocol without the advance written consent of Sponsor, unless in the good medical judgment of Principal Investigator, a deviation is necessary to protect the safety of a Study Subject. If there is any conflict between the terms contained in the Protocol and this Agreement, the terms of the Protocol shall govern and control with respect to clinical, scientific, and medical matters and the terms of the Agreement shall govern and control with respect to all other matters, including by way of example, legal, regulatory, and financial matters. 1.2. Protokol je součástí této Smlouvy a je v tomto dokumentu začleněn formou odkazu. Protokol je součástí této Smlouvy a je do ní začleněn odkazem. Zdravotnické zařízení ani Hlavní zkoušející se neodchýlí od Protokolu bez předchozího písemného souhlasu Zadavatele, ani to žádnému z Personálu studie nedovolí, ledaže by podle správného lékařského úsudku Hlavního zkoušejícího byla odchylka nutná k ochraně bezpečnosti subjektu Studie. V případě jakéhokoli...
Sample 1
Performance of the Study 1. Provádění studie 1.1. Institution and Principal Investigator shall conduct the Study and cause any Study Staff to conduct the Study in accordance with this Agreement, the Protocol (including any subsequent amendments), all Study Instructions, Applicable Law namely Act No. 378/2007 Coll., on Pharmaceuticals, as amended and Decree No. 226/2008 Coll. on good clinical practice and detailed conditions of clinical trials on medicinal products, as amended and any applicable professional standards as in force at the time of performance of the Study (e.g. International Conference on Harmonization-Good Clinical Practice) or as they may be amended or replaced at any time.
Sample 1
Performance of the Study 1. Provádění studie 1.1. Institution and Principal Investigator shall conduct the Study, and shall cause Study Staff to conduct the Study in accordance with this Agreement, the Protocol (including any subsequent amendments), all Study Instructions, Applicable Laws, namely Act No. 378/2007 Coll., on Pharmaceuticals, as amended and Decree No. 226/2008 Coll. on good clinical practice and detailed conditions of clinical trials on medicinal products, as amended, by Act No. 372/2011 Coll., on health services, as amended, and Act No. 110/2019 Coll., on the processing of personal data, as amended, and any professional standards applicable to their professional industries as in force at the time of performance of the Study (e.g., International Conference on Harmonization-Good Clinical Practice) or as they may be amended or replaced at any time.
Sample 1
Performance of the Study 1. Provádění studie 1.1. Institution and Principal Investigator shall conduct the Study and cause any Study Staff to 1. 1. Zdravotnické zařízení a Hlavní zkoušející budou provádět Studii a přimějí veškerý
Sample 1
Performance of the Study 1 
Sample 1Sample 2Sample 3See All (5)
AutoNDA by SimpleDocs

Related to Performance of the Study 1

  • Performance of the Services In addition to the Common Articles, it is specified that:

  • Performance of the Work The Contractor shall perform all of the Work required for the complete and prompt execution of everything described or shown in, or reasonably implied from the Contract Documents for the above referenced Project.

  • PERFORMANCE OF THE CONTRACT II.1.1. The Contractor shall perform the Contract to the highest professional standards. The Contractor shall have sole responsibility for complying with any legal obligations incumbent on him, notably those resulting from employment, tax and social legislation. II.1.2. The Contractor shall have sole responsibility for taking the necessary steps to obtain any permit or licence required for performance of the Contract under the laws and regulations in force at the place where the tasks assigned to him are to be executed. II.1.3. Without prejudice to Article II.3 any reference made to the Contractor’s staff in the Contract shall relate exclusively to individuals involved in the performance of the Contract. II.1.4. The Contractor must ensure that any staff performing the Contract have the professional qualifications and experience required for the execution of the tasks assigned to them. II.1.5. The Contractor shall neither represent the Agency nor behave in any way that would give such an impression. The Contractor shall inform third parties that he does not belong to the European public service. II.1.6. The Contractor shall have sole responsibility for the staff who execute the tasks assigned to him. II.1.7. In the event of disruption resulting from the action of a member of the Contractor's staff working on Agency premises or in the event of the expertise of a member of the Contractor's staff failing to correspond to the profile required by the Contract, the Contractor shall replace him without delay. The Agency shall have the right to request the replacement of any such member of staff, stating its reasons for so doing. Replacement staff must have the necessary qualifications and be capable of performing the Contract under the same contractual conditions. The Contractor shall be responsible for any delay in the execution of the tasks assigned to him resulting from the replacement of staff in accordance with this Article. II.1.8. Should any unforeseen event, action or omission directly or indirectly hamper execution of the tasks, either partially or totally, the Contractor shall immediately and on his own initiative record it and report it to the Agency. The report shall include a description of the problem and an indication of the date on which it started and of the remedial action taken by the Contractor to ensure full compliance with his obligations under the Contract. In such event the Contractor shall give priority to solving the problem rather than determining liability. II.1.9. Should the Contractor fail to perform his obligations under the Contract in accordance with the provisions laid down therein, the Agency may - without prejudice to its right to terminate the Contract - reduce or recover payments in proportion to the scale of the failure. In addition, the Agency may impose penalties or liquidated damages provided for in Article II.16.

  • Performance of Reviews The RIRs shall send a request for review to the Operator per email, where they shall specify the areas they request a review for. The Operator must comply with the request by providing the requested information within working days. The review may include an onsite inspection. In this case the RIRs and the Operator must agree on a specific date for the inspection to take place, which may not be later than sixty calendar days from the date of the request.

  • Performance of the Company The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by this Agreement and the Registration Rights Agreement to be performed, satisfied or complied with by the Company at or prior to the Commencement. The Company shall deliver to the Investor on the Commencement Date the compliance certificate substantially in the form attached hereto as Exhibit C (the “Compliance Certificate”).

  • Performance of Work a. Contractor shall perform all Work in a good and workmanlike manner. Contractor shall maintain sufficient staff and crews to perform all Work in an expeditious manner consistent with the interests of the Park District. Contractor shall promptly notify the Park District immediately in writing: (i) of any information required from the Park District and necessary for Contractor to complete its Work in a timely manner; and (ii) of any Work requested by the Park District or required for the project that is not included in the scope of Work reflected in the Contract Documents. Contractor shall be solely responsible for means and methods selected in performing the Work. Contractor shall supervise all Work so that it is performed in a safe and expeditious manner. Contractor shall be solely responsible for the Work of its employees and its subcontractors’ and suppliers’ employees. Contractor shall keep all documents and information related to the project confidential and, except as required by law, shall not disclose such documents or information to any person or other party except the employees of Contractor and its subcontractors who need such documents or information to perform the Work and complete the project. b. Contractor shall confine all equipment, the storage of materials and the operations of its workers, to limits indicated by law, ordinances, permits, or directions of the Park District and shall not unreasonably encumber the project site with such materials. The project site shall not be utilized for the storage of vehicles, materials, equipment, or fixtures not intended for the Work to be performed. c. Contractor shall notify all utility companies, public and private, as necessary in advance of commencing performance of the Work. The responsibility for moving water lines, gas lines, wire lines, service connections, water and gas meter boxes, water and gas valve boxes, light standards, cable ways, signals and all other utility appurtenances which are within the limits of the proposed construction will be assumed by the Contractor, at no additional compensation. The Contractor shall verify the location of all utilities prior to the start of construction and shall be responsible for the preservation of existing utility installation and the cost of providing precautionary supports, braces, or other equipment to insure against damage to said utility installation. The cost to repair and replace any new or existing utilities damaged will be paid for by the Contractor. d. If Contractor uncovers or discovers any concealed condition differing materially from conditions depicted in the Contract Documents or differing from conditions reasonably anticipated or inherent in the Work, Contractor shall immediately stop the Work and notify the Park District of the condition in writing. The Park District shall then issue written directions. Contractor shall not proceed with the Work until the Park District has issued written directions. The contract time and Contract Sum shall be equitably adjusted if necessitated by such directions of the Park District.

  • Performance of Work by City If the Contractor fails to perform the Work in accordance with the schedule referred to in section 2 above, the City may, in its discretion, in order to bring the project closer to the schedule, perform or cause to be performed some or all of the Work, and doing so shall not waive any of the City’s rights and remedies. Before doing so, the City shall give the Contractor notice of its intention. The Contractor shall reimburse the City for additional costs incurred by the City in exercising its right to perform or cause to be performed some or all of the Work pursuant to this section.

  • Development Program RWJPRI shall be [**] and have [**] in consultation with the JDAC, to select LICENSED COMPOUNDS which shall then be designated PRODUCTS for further DEVELOPMENT by RWJPRI and marketing by ORTHO and its AFFILIATES. RWJPRI shall provide KOSAN with written notice of its decision to select a LICENSED COMPOUND for DEVELOPMENT. Once a PRODUCT has been selected for further DEVELOPMENT, RWJPRI, with the advice of the JDAC, shall have the [**] right to develop the PRODUCT through STAGES O, I, II and III and shall have the [**] right to prepare and file, and shall be the owner of, all applications for MARKETING AUTHORIZATION throughout the world. During such DEVELOPMENT efforts, KOSAN will assist RWJPRI as may be mutually agreed, at RWJPRI's expense, in chemical development, formulation development, production of labeled material and production of sufficient quantities of material for STAGE O and initial STAGE I studies. RWJPRI shall exercise diligent efforts, commensurate with the efforts it would normally exercise for products with similar potential sales volume and consistent with its overall business strategy, in developing such PRODUCT in accordance with the DEVELOPMENT PLAN established by RWJPRI. In the course of such efforts RWJPRI shall, either directly or through an AFFILIATE or SUBLICENSEE to which the license shall have been extended, take appropriate steps including the following: (i) in consultation with the JDAC, select certain LICENSED COMPOUNDS for STAGE O DEVELOPMENT; and (ii) establish and maintain a program reasonably designed, funded and resourced to obtain information adequate to enable the preparation and filing with an appropriate and properly empowered national regulatory authority all necessary documentation, data and [**] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. other evidence required for IND non-rejection to commence and conduct human clinical trials of such PRODUCT. (iii) proceed following IND non-rejection to commence PHASE I, II, and III clinical trials, associated studies and such other work which RWJPRI reasonably deems to be required for subsequent inclusion in filings for MARKETING AUTHORIZATION; (iv) after such submissions are filed prosecute such submissions and file all reasonably necessary, reports and respond to all reasonable requests from the pertinent regulatory, authorities for information, data, samples, tests and the like.

  • Performance of Agreement Seller and its Affiliates shall have performed in all material respects all of their covenants, agreements and obligations required by this Agreement to be performed or complied with by them prior to or upon the Closing.

  • Research Program The term “Research Program” shall mean the research program to be undertaken by TSRI under the direction and control of the Principal Investigator as expressly set forth on Exhibit A hereto.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!